Matthew Lamb, hospital director at Nuffield Health Newcastle Hospital, said: “Being at the forefront of advancements in medical and surgical technologies is a key priority for us, which is why we are delighted to provide the rectal spacer procedure to prostate cancer patients in the region who need it. This is a vital development in cancer care and demonstrates our commitment to working with public and private bodies to ensure the best patient outcomes.”
Stephen McGill, Vice President and General Manager International for SpaceOAR Hydrogel, said: “With the support of our clinical data more than 50,000 men worldwide are now benefiting from the long-term positive impact of SpaceOAR. Our aim has always been to provide spacing to men throughout the UK. We are excited this collaboration is another step forward in helping to provide further access to prostate cancer patients throughout the North East.”
The Rutherford Cancer Centre North East is part of a network of cancer centres across the UK that offers high energy proton beam therapy and the only centre to do so in the region. The centre also offers conventional cancer treatments such as chemotherapy, immunotherapy and radiotherapy. In August it announced a partnership with Northumbria Healthcare NHS Trust that enabled NHS patients to be treated at the centre with chemotherapy.